Paysign, Inc. (PAYS)
Market Cap | 177.78M |
Revenue (ttm) | 56.47M |
Net Income (ttm) | 8.07M |
Shares Out | 53.55M |
EPS (ttm) | 0.14 |
PE Ratio | 23.97 |
Forward PE | 47.43 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 71,203 |
Open | 3.400 |
Previous Close | 3.400 |
Day's Range | 3.320 - 3.410 |
52-Week Range | 2.230 - 5.590 |
Beta | 0.94 |
Analysts | Strong Buy |
Price Target | 6.17 (+85.84%) |
Earnings Date | Nov 5, 2024 |
About PAYS
Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card. Th... [Read more]
Financial Performance
In 2023, Paysign's revenue was $47.27 million, an increase of 24.30% compared to the previous year's $38.03 million. Earnings were $6.46 million, an increase of 528.42%.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for PAYS stock is "Strong Buy." The 12-month stock price forecast is $6.17, which is an increase of 85.84% from the latest price.
News
Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth
Paysign is a promising microcap payment processing company with a projected 42% annualized return, potentially reaching $19/share by 2030 from $3.30/share today. The company excels in two primary sect...
Paysign, Inc. (PAYS) Q3 2024 Earnings Call Transcript
Paysign, Inc. (NASDAQ:PAYS) Q3 2024 Earnings Conference Call November 5, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President, Patient Affor...
Paysign, Inc. Reports Third Quarter 2024 Financial Results
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated paym...
Paysign to Host Third Quarter 2024 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2024 Earnings Call.
Paysign: The Return Of The King Of Medical Fintech
Niche Focus: Paysign specializes in healthcare payment solutions, primarily in plasma donor compensation and patient affordability programs. Revenue Growth: Significant growth in the patient affordabi...
Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference.
Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference.
Paysign, Inc. (PAYS) Q2 2024 Earnings Call Transcript
Paysign, Inc. (NASDAQ:PAYS) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President of Patient Afford...
Paysign, Inc. Reports Second Quarter 2024 Financial Results
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Second Quarter 2024 Financial Results.
Paysign to Host Second Quarter 2024 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Second Quarter 2024 Earnings Call.
Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25.
Paysign, Inc. to Participate in the 2024 iAccess Alpha Buyside Best Ideas Summer Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated paym...
Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference.
Paysign, Inc. (PAYS) Q1 2024 Earnings Call Transcript
Paysign, Inc. (NASDAQ:PAYS) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President of Patient Affordabi...
Paysign, Inc. Reports First Quarter 2024 Financial Results
First quarter 2024 total revenues of $13.2 million, up 30% from first quarter 2023 First quarter 2024 net income of $309 thousand, or diluted earnings per share of $0.01, versus net loss of $160 thous...
Paysign to Host First Quarter 2024 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2024 Earnings Call.
Driving Growth And Innovation Are Drivers Of PaySign's Success In The Prepaid Card Industry
PaySign continues to experience double-digit net sales growth driven by investments in prepaid card-based payment solutions for the plasma donation industry. The company has a strong presence with 465...
PaySign, Inc. (PAYS) Q4 2023 Earnings Call Transcript
PaySign, Inc. (PAYS) Q4 2023 Earnings Call Transcript
Paysign, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results
For the Full Year Full-year 2023 total revenues of $47.3 million, up 24% from full-year 2022 Full-year 2023 net income of $6.5 million, or diluted earnings per share of $0.12, versus net income of $1....
Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17
ATHENS, Greece--(BUSINESS WIRE)-- #IPPC2024--Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17.
Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire
HENDERSON, Nev.--(BUSINESS WIRE)-- #executiveteam--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services an...
Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29
BOSTON--(BUSINESS WIRE)-- #patientaffordability--Payysign, Inc. to sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29.
Paysign Inc. to Sponsor the 2024 ACCESS USA Conference March 19-21
PHILADELPHIA--(BUSINESS WIRE)--Paysign Inc. to Sponsor the 2024 ACCESS USA Conference March 19-21.
Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated pay...
PaySign, Inc. (PAYS) Q3 2023 Earnings Call Transcript
PaySign, Inc. (NASDAQ:PAYS) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Mark Newcomer - Chief Executive Officer Jeff Baker - Chief Financial Officer Conference C...